Lantheus Holdings, Inc. (LNTH)
63.11
+2.29
(+3.77%)
USD |
NASDAQ |
Dec 11, 16:00
63.23
+0.12
(+0.19%)
After-Hours: 20:00
Lantheus Holdings Cash from Investing (Quarterly): -319.47M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Cytokinetics, Inc. | -70.98M |
| Integra LifeSciences Holdings Corp. | -15.59M |
| Iovance Biotherapeutics, Inc. | 17.01M |
| Tandem Diabetes Care, Inc. | 20.54M |
| Day One Biopharmaceuticals, Inc. | 13.46M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 105.29M |
| Cash from Financing (Quarterly) | -99.17M |
| Free Cash Flow | 411.69M |
| Free Cash Flow Per Share (Quarterly) | 1.399 |
| Free Cash Flow to Equity (Quarterly) | 90.73M |
| Free Cash Flow to Firm (Quarterly) | 97.92M |
| Free Cash Flow Yield | 9.36% |